Susan J. Hayflick

Susan J. Hayflick, M.D., FACMG

Professor and Chairman of Molecular and Medical Genetics,
Professor of Pediatrics and Neurology, Oregon Health & Science University

View Bio >
Alaa Koleilat

Alaa Koleilat, Ph.D., FACMG

Medical Director, Cytogenetics and Inherited Molecular Genetics, Knight Diagnostic Laboratories Oregon Health & Science University

View Bio >
Susan B. Olson

Susan B. Olson, Ph.D., FACMG

Medical Director, Cytogenetics and Interim Co-Executive Director, Knight Diagnostic Laboratories Oregon Health & Science University
Professor of Molecular and Medical Genetics, OHSU

View Bio >
Richard D. Press

Richard D. Press, M.D., Ph.D.

Medical Director, Molecular Genetic Pathology and Interim Co-Executive Director
Knight Diagnostic Laboratories, Oregon Health & Science University Professor of Pathology, OHSU

View Bio >
Sue Richards

Sue Richards, Ph.D., FACMG

Medical Director, The Healthy Oregon Project, Knight Diagnostic Laboratories
Professor Emeritus, Department of Molecular and Medical Genetics
Oregon Health & Science University

View Bio >
George Thomas

George Thomas, M.D.

Medical Director, Histopathology Shared Services
PROFESSOR OF PATHOLOGY, OHSU

View Bio >
Joanna Pucilowska

Joanna Pucilowska, MS, PhD

Interim Knight Diagnostics Co-Director,
Director, Immune Monitoring and Cancer Omics Services
Scientific Partnerships and Business Development, Oncology

View Bio >
Christopher Suciu

Christopher Suciu, M.D., M.S.

ASSISTANT PROFESSOR OF PATHOLOGY, OHSU
Medical DIRECTOR, Molecular Genetic Pathology and Bioinformatics, KNIGHT DIAGNOSTIC LABORATORES, OREGON HEALTH & SCIENCE UNIVERSITY

View Bio >
Innovations in Testing
View All Tests

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More